Skip to main content

Hexagon Capital Partners LLC

Position in NVS — Novartis AG

CIK 1831542 ROGERS, AR

Position in NVS

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$625,312
+$47,459 QoQ
Shares Held
3,990
+5.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#794
of 1,603 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority Sole 27% Shared 0% None 73%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Hexagon Capital Partners LLC holds $11,707,728 across 11 Drug Manufacturers - General names. NVS ranks #8 (5.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVS
Novartis AG
This page
3,990 $625,312

All Filings in NVS

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $625,312 3,990
2026-03-31 $577,853 3,783
2025-03-31 $352,611 3,163
2024-12-31 $315,284 3,240
2024-09-30 $401,994 3,495
2024-06-30 $378,997 3,560
2024-03-31 $349,485 3,613
2023-12-31 $389,138 3,854
2023-09-30 $273,290 2,683
2023-06-30 $255,201 2,529
2023-03-31 $195,960 2,130
2022-12-31 $178,718 1,970
2022-09-30 $151,107 1,988
2022-06-30 $127,048 1,503
2022-03-31 $87,925 1,002
2021-12-31 $79,160 905
2021-09-30 $74,010 905
2021-06-30 $82,572 905
2021-03-31 $77,359 905
2020-12-31 $101,795 1,078
2020-09-30 $93,742 1,078